| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.3M | +14.2% | +61.4% |
| R&D Expense | $5K | -36.8% | -54.4% |
| SG&A Expense | $5.3M | +3.5% | +39.0% |
| Operating Income | -$1.1M | +27.0% | +11.5% |
| Interest Expense | $126K | +1.1% | +0.0% |
| Net Income | -$1.2M | +26.4% | +11.9% |
| EPS (Basic) | -$0.45 | +27.4% | +52.1% |
| EPS (Diluted) | -$0.45 | +27.4% | +52.1% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.6M | -4.0% | +2.1% |
| Accounts Receivable | $3.2M | +9.8% | +57.7% |
| Inventory | $600K | -6.5% | +21.6% |
| Current Assets | $15.5M | -2.5% | +10.7% |
| Total Assets | $15.6M | -2.6% | +10.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.1M | — | — |
| Financing Cash Flow | $64K | — | — |
| $12.2M |
| +5.3% |
| +25.3% |
| Total Liabilities | $12.3M | +5.1% | +25.8% |
| Stockholders' Equity | $3.4M | -23.1% | -23.4% |